Customized Biospecimen Collection and Analysis
Advancing respiratory drug discovery requires high-quality, disease-relevant biospecimens that accurately reflect pulmonary pathophysiology. At Ace Therapeutics, we offer fully customizable biospecimen collection and analysis services designed specifically for preclinical respiratory research. Whether you are investigating asthma, COPD, pulmonary fibrosis, or acute lung injury, our team works closely with you to develop protocols that align precisely with your study objectives, ensuring reliable and reproducible data for confident decision-making.
We understand that every respiratory disease model presents unique challenges. Our flexible collection strategies cover a wide spectrum of sample types from rodents to larger preclinical species, with protocols adapted to acute, chronic, or intervention-based study designs.
| Sample Type | Collection Method | Typical Downstream Analyses |
| Bronchoalveolar Lavage Fluid (BALF) | Tracheal cannulation with controlled instillation/aspiration | Total & differential cell counts, cytokine/chemokine profiling, lipid mediator analysis |
| Lung Tissue | Perfusion-fixed (paraffin-embedded) or snap-frozen | Histopathology (H&E, Masson's trichrome), immunohistochemistry, hydroxyproline assay, RNA/protein extraction |
| Blood / Plasma / Serum | Cardiac puncture (rodents) or venous access (larger models) | Clinical chemistry, biomarker ELISAs, drug concentration measurement, flow cytometry |
| Nasal Lavage Fluid | Gentle flushing of the nasal cavity | Inflammatory markers (e.g., IgE, IL-13), mucin quantification, microbial analysis |
| Exhaled Breath Condensate (EBC) | Custom condensation collection (for suitable species) | pH, volatile organic compounds, selected cytokines (upon request) |
| Induced Sputum (select models) | Osmotic challenge or mechanical stimulation | Mucus properties, cellularity, inflammatory mediators |
Protocols are available for mouse, rat, guinea pig, and non‑human primate models. Collection time points and processing conditions (e.g., fresh, frozen, fixed) are defined collaboratively to match your endpoints.
Our laboratory employs a broad range of state‑of‑the‑art analytical techniques, allowing us to customize the readout to your specific biomarkers and mechanistic pathways.
Ace Therapeutics is dedicated exclusively to respiratory diseases, giving us deep insight into the unique challenges of preclinical pulmonary research. Our scientific team combines years of experience in pharmacology, pathology, and molecular biology to provide you with data you can trust. By offering fully customizable biospecimen solutions, we empower you to extract maximum value from every animal study, whether you are validating a target, profiling a drug candidate, or exploring disease mechanisms.
Contact Ace Therapeutics today to discuss your respiratory disease research needs. Together, we will build a tailored biospecimen collection and analysis plan that delivers the high‑quality data required to advance your preclinical programs.
What types of respiratory disease models do you support for biospecimen collection?
We support a wide range of preclinical models, including allergen‑induced asthma, cigarette smoke‑induced COPD, bleomycin‑induced pulmonary fibrosis, LPS‑induced acute lung injury, and various infectious or genetic models. Our protocols are adaptable to both acute and chronic study designs.
Can you customize biospecimen collection based on my specific endpoints?
Absolutely. We work closely with you to design collection schedules, sample types, and processing methods tailored to your unique research questions – whether you need BALF for cellular analysis, lung tissue for histology, or blood for pharmacokinetics.
What analytical platforms are available for biospecimen analysis?
Our laboratory is equipped with multiplex immunoassay systems, flow cytometers, real‑time PCR instruments, and advanced imaging for histopathology. We also offer specialized assays such as hydroxyproline measurement, mucus staining, and lipid mediator analysis by LC‑MS upon request.
How do you ensure sample quality and reproducibility?
We follow strictly validated SOPs for every step – collection, processing, and storage. Each procedure is documented, and quality control checks (e.g., cell viability, RNA integrity) are performed as appropriate. If samples need to be collected at your facility, we provide detailed instructions and training.
Do you provide support for shipping and handling of collected biospecimens?
Yes. We offer guidance on proper sample preservation and shipping conditions (e.g., dry ice, RNA later) to maintain analyte stability. We can also coordinate sample pickup and ensure compliance with applicable regulations.
Can you assist with study design and endpoint selection?
Certainly. Our scientific team has extensive experience in respiratory pharmacology and can advise on appropriate biomarkers, sample sizes, and collection time points to maximize the value of your study.
Make Order
Experimental Scheme
Implementation
Conclusion
Ace Therapeutics is a preclinical research organization focused on respiratory diseases. We provide validated models and rigorous analysis services to support the development of novel therapeutics, from concept to preclinical insight.